⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

November 29, 2025Malaria JournalOpen Access

Community evaluation of VECTRON™ T500 (broflanilide) for indoor residual spraying for malaria vector control in Siaya county, Kenya

Celestine N. Wekesa Brian Polo Margaret Muchoki Bernard Abong’o Paul Kiptoo Patrick Mburugu David Sang

View Full Paper

Ask AI

Bookmark

Share

Abstract

VECTRON™ T500 demonstrated superior residual efficacy, excellent safety profile, and high community acceptance compared to Actellic™ 300CS. Its novel mode of action and absence of cross-resistance to pirimiphos-methyl and pyrethroids make it valuable for insecticide resistance management in malaria vector control programmes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wekesa et al. (2025) studied this question.

synapsesocial.com/papers/69402de12d562116f2903ac9 https://doi.org/10.1186/s12936-025-05688-w

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Community evaluation of VECTRON™ T500 (broflanilide) for indoor residual spraying for malaria vector control in Siaya county, Kenya2025
2Long-lasting residual efficacy of a new Indoor Residual Spraying product, VECTRON™ T500 (broflanilide), against pyrethroid-resistant malaria vectors and its acceptance in a community trial in Burkina Faso2024
3Determination of the Residual Efficacy of Broflanilide (VECTRONTM T500) Insecticide for Indoor Residual Spraying in a Semi-field Setting in Ethiopia2024 · 1 citations
4Determination of the Preliminary Discriminating Concentration of Broflanilide Against Malaria Vector Mosquito Anopheles gambiae by Multi-Centre Susceptibility Testing2025
5Efficacy of Pirikool® 300 CS used for indoor residual spraying on three different substrates in semi-field experimental conditions2024 · 2 citations